China’s Healthcare Boom: Epredia Triples Shanghai Output Amid Global Investment Surge
U.S.-based diagnostics firm Epredia has tripled its Shanghai output in two years, showcasing China’s booming healthcare market and its appeal to global investors.
Epredia Expansion
Read More